Phase 1/2a for Safety, PK and PD of SQY51 in Paediatric and Adult Patients Duchenne Muscular Dystrophy

Clinical trial NCT05753462 · UNKNOWN

Trial details

NCT number: NCT05753462
Sponsor: Sqy Therapeutics
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Duchenne Muscular Dystrophy

Start date: 2023-04-26
Primary completion: 2025-02-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.